USPTO serial 88020634
EARLI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 14, 2023
- Examiner
- LEE, DOUGLAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EARLI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mountain View, CA
Mountain View, CA
Mountain View, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Connie L. Ellerbach
Connie L. Ellerbach FENWICK & WEST LLP801 CALIFORNIA STREETMOUNTAIN VIEW, CA 94041UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use | ACTIVE | Jan 18, 2023 |
| 005 | Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases | ACTIVE | Jan 18, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 14, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 9, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 2, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 31, 2023 | IUAF | USE AMENDMENT FILED | — |
| Jan 31, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 18, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 17, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 4, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 15, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 15, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 16, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 14, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 14, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 14, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 16, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 16, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 16, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 14, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 14, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 22, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 22, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 14, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 4, 2020 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 13, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 9, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 20, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 20, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 20, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 3, 2018 | NWAP | NEW APPLICATION ENTERED | — |